Nisin resistance in Gram-positive bacteria and approaches to circumvent resistance for successful therapeutic use.
Listeria monocytogenes
Staphylococcus aureus
bacteriocins
bioengineering
combination therapy
Journal
Critical reviews in microbiology
ISSN: 1549-7828
Titre abrégé: Crit Rev Microbiol
Pays: England
ID NLM: 8914274
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
pubmed:
11
3
2021
medline:
14
5
2021
entrez:
10
3
2021
Statut:
ppublish
Résumé
Antibiotic resistance among bacterial pathogens is one of the most worrying problems in health systems today. To solve this problem, bacteriocins from lactic acid bacteria, especially nisin, have been proposed as an alternative for controlling multidrug-resistant bacteria. Bacteriocins are antimicrobial peptides that have activity mainly against Gram-positive strains. Nisin is one of the most studied bacteriocins and is already approved for use in food preservation. Nisin is still not approved for human clinical use, but many
Identifiants
pubmed: 33689548
doi: 10.1080/1040841X.2021.1893264
doi:
Substances chimiques
Anti-Bacterial Agents
0
Nisin
1414-45-5
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM